Invention Grant
- Patent Title: EP1 receptor ligands
- Patent Title (中): EP1受体配体
-
Application No.: US14345136Application Date: 2012-09-14
-
Publication No.: US09518015B2Publication Date: 2016-12-13
- Inventor: Antoni Torrens Jover , Ramon Mercè Vidal , Francesc Xavier Caldentey Frontera , Antonio David Rodríguez Garrido , Elena Carceller González , Jordi Salas Solana
- Applicant: Antoni Torrens Jover , Ramon Mercè Vidal , Francesc Xavier Caldentey Frontera , Antonio David Rodríguez Garrido , Elena Carceller González , Jordi Salas Solana
- Applicant Address: ES Barcelona
- Assignee: LABORATORIOS DEL DR. ESTEVE, S.A.
- Current Assignee: LABORATORIOS DEL DR. ESTEVE, S.A.
- Current Assignee Address: ES Barcelona
- Agency: Ostrolenk Faber LLP
- Priority: EP11382296 20110916
- International Application: PCT/EP2012/068101 WO 20120914
- International Announcement: WO2013/037960 WO 20130321
- Main IPC: C07D209/12
- IPC: C07D209/12 ; C07D209/34 ; C07D405/06 ; C07D209/42 ; C07D215/48 ; C07D235/06 ; C07D471/04 ; C07D209/08 ; C07D231/56 ; C07D401/06 ; C07D405/12 ; C07D241/42 ; C07D487/04 ; C07D265/36
Abstract:
The present invention belongs to the field of EP1 receptor ligands. More specifically it refers to compounds of general formula (I) having great affinity and selectivity for the EP1 receptor. The invention also refers to the process for their preparation, to their use as medicament for the treatment and/or prophylaxis of diseases or disorders mediated by the EP1 receptor as well as to pharmaceutical compositions comprising them.
Public/Granted literature
- US20140323475A1 EP1 RECEPTOR LIGANDS Public/Granted day:2014-10-30
Information query
